Search Results - "Tu, Zhi‐Hui"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    MicroRNA‐214‐5p aggravates sepsis‐related acute kidney injury in mice by Guo, Cheng, Ye, Fang‐Xiong, Jian, Yong‐Hong, Liu, Chun‐Hua, Tu, ZhiHui, Yang, Ding‐Ping

    Published in Drug development research (01-04-2022)
    “…Acute kidney injury (AKI) is a devastating comorbidity in sepsis and correlates with a very poor prognosis and increased mortality. Currently, we use…”
    Get full text
    Journal Article
  2. 2

    Efficacy and safety of two dose regimens of rituximab for idiopathic membranous nephropathy by Zhi-hui Tu, Ding-ping Yang

    Published in Linchuang Shenzangbing Zazhi (01-02-2024)
    “…ObjectiveTo compare the clinical efficacy and safety of two regimens of rituximab (RTX) for idiopathic membranous nephropathy (IMN).MethodsA total of 79 IMN…”
    Get full text
    Journal Article
  3. 3

    Analysis of corneal morphologic and pathologic changes in early-stage congenital aniridic keratopathy by Du, Juan, Liu, Rong-Qiang, Ye, Lei, Li, Zhi-Hui, Zhao, Feng-Tu, Jiang, Nan, Ye, Lin-Hong, Shao, Yi

    Published in International journal of ophthalmology (18-03-2017)
    “…AIM:To determine typical corneal changes of congenital aniridic keratopathy(CAK)using corneal topography and confocal systems,and to identify characteristics…”
    Get full text
    Journal Article
  4. 4

    不同剂量利妥昔单抗治疗特发性膜性肾病的有效性和安全性 by 涂志辉, 杨定平

    Published in 临床肾脏病杂志 (2024)
    “…目的 对比两种不同剂量利妥昔单抗方案治疗特发性膜性肾病患者的临床疗效.方法 选取 2019年 12月 1日至 2021年 12月 31日经武汉大学人民医院诊断为特发性膜性肾病的患者,共 79例.利妥昔单抗两剂方案组(49例):1 g/次,第 1、15 天各用 1次,如随访 6个月时仍有肾病范围的蛋白尿,重复该方案…”
    Get full text
    Journal Article